The global healthcare contract research organization (CRO‘s) market size was valued at USD 28.2 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.2% from 2021 to 2028.
The market is driven by the increasing demand for clinical trials, the rising number of drug approvals, and the growing demand for outsourcing services. The increasing number of clinical trials and the rising demand for outsourcing services are expected to drive the growth of the market.
Additionally, the increasing number of drug approvals and the growing demand for personalized medicine are expected to further drive the growth of the market.
The increasing demand for clinical trials is expected to drive the growth of the market. Clinical trials are conducted to evaluate the safety and efficacy of new drugs and medical devices. The increasing number of clinical trials is expected to drive the growth of the market.
Additionally, the increasing demand for outsourcing services is expected to further drive the growth of the market. Outsourcing services are used to reduce costs and improve efficiency. The increasing demand for outsourcing services is expected to drive the growth of the market.
The increasing number of drug approvals is expected to drive the growth of the market. The increasing number of drug approvals is expected to drive the growth of the market.
Additionally, the growing demand for personalized medicine is expected to further drive the growth of the market. Personalized medicine is used to tailor treatments to individual patients based on their genetic makeup. The increasing demand for personalized medicine is expected to drive the growth of the market.
The increasing demand for clinical trials and the rising number of drug approvals are expected to drive the growth of the market. Additionally, the growing demand for personalized medicine and the increasing demand for outsourcing services are expected to further drive the growth of the market.
|